Mississauga, Ontario - Rumours that Toronto-based Vasogen Incorporated’s new Celacade treatment for heart failure, also referred to as Acclaim II, is a failed drug and that clinical trials for t… more →
Business History Todaywarrenh wrote 2 months ago: Mississauga, Ontario - Rumours that Toronto-based Vasogen Incorporated’s new Celacade treatmen … more →